Physician

Sachin S Mudvari, MD

According to 2025 Medicare claims, Sachin Mudvari, MD (NPI: 1023221199) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27514-7092.

Mudvari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 740 traditional Medicare patients, billed 31,642 HCPCS/CPT codes, and received $3,728,230 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 164 prescription claims across 71 beneficiaries totaling $6,920 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 24 records totaling $736. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $9,698 to $6,920. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.7M2015 Medicare payment: $2,913,515 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,903,809 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,298,930 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,277,150 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,512,902 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,383,597 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,090,605 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,073,393 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,217,242 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,728,230 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201569611,647$2,913,515
201672611,373$2,903,809
201779413,326$3,298,930
201875513,100$3,277,150
201981913,852$3,512,902
202072712,556$3,383,597
202176011,999$3,090,605
202274712,994$3,073,393
202374421,289$3,217,242
202474031,642$3,728,230

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.0K$16K2015 Drug cost: $9,698 (USD; Tot_Drug_Cst)2016 Drug cost: $7,920 (USD; Tot_Drug_Cst)2017 Drug cost: $11,081 (USD; Tot_Drug_Cst)2018 Drug cost: $16,059 (USD; Tot_Drug_Cst)2019 Drug cost: $15,033 (USD; Tot_Drug_Cst)2020 Drug cost: $15,798 (USD; Tot_Drug_Cst)2021 Drug cost: $9,621 (USD; Tot_Drug_Cst)2022 Drug cost: $3,921 (USD; Tot_Drug_Cst)2023 Drug cost: $3,049 (USD; Tot_Drug_Cst)2024 Drug cost: $6,920 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201566159$9,698
201660135$7,920
201777214$11,081
201875219$16,059
201995232$15,033
202069149$15,798
202165140$9,621
202251103$3,921
202358114$3,049
202471164$6,920

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0177Injection, aflibercept hd, 1 mg1634,904$260
67028Injection of drug into eye3751,711$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more411517$62
92134Imaging of retina3701,311$28
92250Photography of the retina647844$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate551,888$1,866
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat281,740$539
LatanoprostLatanoprost12262$225
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13171$185
TobramycinTobramycin31752$134

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$736Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sachin S. Mudvari, MD?

Tedicare shows public-source Medicare data for Sachin S. Mudvari, MD (NPI 1023221199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sachin S. Mudvari, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sachin S. Mudvari, MD?

Sachin S. Mudvari, MD is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Sachin S. Mudvari, MD have Open Payments data?

Sachin S. Mudvari, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.